Mitchell P. Kopin 13D/13G Filings for

Mitchell P. Kopin 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-06
10:27 am
Sale
2023-12-31 13G Kiora Pharmaceuticals, Inc.
KPRX
Mitchell P. Kopin 13,012
1.500%
-6,185decrease
(-32.22%)
Filing
2023-02-08
06:07 am
Purchase
2022-12-31 13G Kiora Pharmaceuticals, Inc.
KPRX
Mitchell P. Kopin 19,197
9.000%
19,197increase
(New Position)
Filing